Neonatology

Resource Center

FDA Alerts

FDA Alert

FDA Approves First Monoclonal Injection to Prevent RSV in Infants, Toddlers

07/24/2023

Jessica Ganga

Following three clinical trials, the FDA has approved a new preventive treatment for neonates, infants, and toddlers that prevents respiratory syncytial virus (RSV) in those age populations.

07/24/2023

Research Summaries

FDA Alert

FDA Approves First Monoclonal Injection to Prevent RSV in Infants, Toddlers

07/24/2023

Jessica Ganga

Following three clinical trials, the FDA has approved a new preventive treatment for neonates, infants, and toddlers that prevents respiratory syncytial virus (RSV) in those age populations.

07/24/2023

Viral Infections

Respiratory Syncytial Virus and Mortality Among Children Aged 5 Years or Younger

06/20/2022

The authors expanded upon research conducted in 2015 by including deaths across different global demographics that did not occur in hospitals. This is the first study to examine the RSV disease burden in...

06/20/2022

April 2024

Current Issue

April 2024

Volume 64

Issue 4